CORRELATION BETWEEN THE PREVALENCE OF GASTRITIS AND GASTRIC-CANCER IN JAPAN

被引:48
作者
FUKAO, A
HISAMICHI, S
OHSATO, N
FUJINO, N
ENDO, N
IHA, M
机构
关键词
CHRONIC ATROPHIC GASTRITIS; CORRELATION STUDY; GASTRIC CANCER; PEPSINOGEN; PRECANCEROUS LESION; JAPAN;
D O I
10.1007/BF00051709
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To verify the hypothesis that chronic atrophic gastritis (CAG) is a precancerous lesion for gastric cancer, we investigated the correlation between the prevalence rates for CAG determined by levels of serum pepsinogens (I and II) of randomly selected, healthy, blood donors and the mortality rates for gastric cancer among four prefectures (Akita, Iwate, Miyagi, and Okinawa) in Japan. The prevalence rates for CAG according to a criterion that the level of pepsinogen I is below 70 ng/ml and the pepsinogen I to pepsinogen II ratio is below 3.0, were the highest in Akita for both sexes (38.8 percent in males, 37.8 percent in females) and the lowest in Okinawa (13.9 percent in males, 12.3 percent in females), where mortality rates for gastric cancer are the highest and the lowest in Japan, respectively. The correlation between the prevalence rates for CAG and the standardized mortality ratios for gastric cancer among these four prefectures was statistically significant in males (r = 0.97, P = 0.03), but less significant in females (r = 0.92, P = 0.08). These data strongly support the hypothesis that CAG is a precancerous lesion. The limitations of our cross-sectional study and the advantages of measuring the levels of serum pepsinogens in epidemiologic studies and in mass-screening programs for gastric cancer are discussed.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 13 条
  • [1] Kawachi T., Kurisu M., Numanyu S., Sasajima K., Sano T., Sugimuma T., Precancerous changes in the stomach, Cancer Res, 36, pp. 2673-7, (1976)
  • [2] Correa P., The gastric precancerous process, Cancer Surveys, 2, pp. 438-50, (1983)
  • [3] Tatsuta M., Seagnsa T., Okuda S., Studies on gastritis in the upper portion of stomach by endoscopic Congo red test, Endoscopy, 5, pp. 61-9, (1973)
  • [4] Samloff I.M., Varis K., Ihamaki T., Siurala M., Rotter J.I., Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology: A study in relatives of patients with pernicious anemia, Gastroenterol, 83, pp. 204-9, (1982)
  • [5] Miki K., Ichinose M., Kawamura N., Et al., The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects, Jpn J Cancer Res, 80, pp. 111-4, (1989)
  • [6] Westerveld B.D., Pols G., Lamers C.B., Et al., Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels, Cancer, 59, pp. 952-8, (1987)
  • [7] Miki K., Ichinose M., Chronic atrophic gastritis and serum pepsinogen levels (in Japanese with English abstract), Jpn J Cancer Clin, 38, pp. 221-9, (1992)
  • [8] Ichinose M., Miki K., Furihata C., Et al., Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders, Clin Chim Acta, 126, pp. 183-91, (1982)
  • [9] Samloff I.M., Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence, Gastroenterol, 61, pp. 185-8, (1971)
  • [10] Samloff I.M., Lieblman W.M., Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence, Gastroenterol, 65, pp. 36-42, (1973)